![Covance starting to rebound, but clinical trial business still being hit by COVID-19 | Fierce Biotech Covance starting to rebound, but clinical trial business still being hit by COVID-19 | Fierce Biotech](https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1603802575/CovanceEvansville_3.jpg/CovanceEvansville_3.jpg?VersionId=ys40sTg3ReHX6gYsZ1IYZwPtUCZAVwJR)
Covance starting to rebound, but clinical trial business still being hit by COVID-19 | Fierce Biotech
Animal Sciences at Rutgers, The State University of New Jersey - Covance Recruitment Event for Jobs & Internships Friday, November 15 in BT-123 Join us ~ and bring a friend! | Facebook
![LabCorp to Acquire Covance for Approximately $6.1 Billion, Creating World's Leading Healthcare Diagnostics Company - New Jersey Business Magazine LabCorp to Acquire Covance for Approximately $6.1 Billion, Creating World's Leading Healthcare Diagnostics Company - New Jersey Business Magazine](https://njbmagazine.com/wp-content/uploads/2014/11/461252089-775x500.jpg)
LabCorp to Acquire Covance for Approximately $6.1 Billion, Creating World's Leading Healthcare Diagnostics Company - New Jersey Business Magazine
![DEF 14A 1 a2207874zdef14a.htm DEF 14A QuickLinks -- Click here to rapidly navigate through this document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section ... DEF 14A 1 a2207874zdef14a.htm DEF 14A QuickLinks -- Click here to rapidly navigate through this document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section ...](https://www.sec.gov/Archives/edgar/data/1023131/000104746912003295/g15062bci002.gif)